Mangiri Amalya, Iuliano A Danielle, Wahyuningrum Yunita, Praptiningsih Catharina Y, Lafond Kathryn E, Storms Aaron D, Samaan Gina, Ariawan Iwan, Soeharno Nugroho, Kreslake Jennifer M, Storey J Douglas, Uyeki Timothy M
US Centers for Disease Control and Prevention, Jakarta, Indonesia.
Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Influenza Other Respir Viruses. 2017 Jan;11(1):93-99. doi: 10.1111/irv.12428. Epub 2016 Oct 27.
Indonesia has reported highest number of fatal human cases of highly pathogenic avian influenza (HPAI) A (H5N1) virus infection worldwide since 2005. There are limited data available on seasonal and pandemic influenza in Indonesia. During 2012, we conducted a survey of clinicians in two districts in western Java, Indonesia, to assess knowledge, attitudes, and practices (KAP) of clinical diagnosis, testing, and treatment of patients with seasonal influenza, pandemic influenza, or HPAI H5N1 virus infections. Overall, a very low percentage of physician participants reported ever diagnosing hospitalized patients with seasonal, pandemic, or HPAI H5N1 influenza. Use of influenza testing was low in outpatients and hospitalized patients, and use of antiviral treatment was very low for clinically diagnosed influenza patients. Further research is needed to explore health system barriers for influenza diagnostic testing and availability of antivirals for treatment of influenza in Indonesia.
自2005年以来，印度尼西亚报告的高致病性禽流感（HPAI）A（H5N1）病毒感染致死人类病例数在全球范围内最多。关于印度尼西亚季节性流感和大流行性流感的数据有限。2012年期间，我们对印度尼西亚爪哇岛西部两个地区的临床医生进行了一项调查，以评估他们对季节性流感、大流行性流感或HPAI H5N1病毒感染患者进行临床诊断、检测和治疗的知识、态度和实践（KAP）。总体而言，参与调查的医生中报告曾诊断住院患者患有季节性、大流行性或HPAI H5N1流感的比例非常低。门诊患者和住院患者中流感检测的使用率较低，临床诊断为流感的患者中抗病毒治疗的使用率也非常低。需要进一步研究以探索印度尼西亚流感诊断检测的卫生系统障碍以及用于治疗流感的抗病毒药物的可及性。
